Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels

PURPOSE: T cells genetically modified to express chimeric antigen receptors (CARs) targeting CD19 (CAR-19) have potent activity against acute lymphoblastic leukemia, but fewer results supporting treatment of lymphoma with CAR-19 T cells have been published. Patients with lymphoma that is chemotherap...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Oncol
Prif Awduron: Kochenderfer, James N., Somerville, Robert P.T., Lu, Tangying, Shi, Victoria, Bot, Adrian, Rossi, John, Xue, Allen, Goff, Stephanie L., Yang, James C., Sherry, Richard M., Klebanoff, Christopher A., Kammula, Udai S., Sherman, Marika, Perez, Arianne, Yuan, Constance M., Feldman, Tatyana, Friedberg, Jonathan W., Roschewski, Mark J., Feldman, Steven A., McIntyre, Lori, Toomey, Mary Ann, Rosenberg, Steven A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2017
Pynciau:
Original Reports
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455597/
https://ncbi.nlm.nih.gov/pubmed/28291388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.71.3024
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg